US Patent Issued to Sun Yat-sen University, Sun Yat-sen University Cancer Center on Sept. 29 for "Use of BMP9 in combination with NK cell and PD-L1 antibody in preparing medicament for treating liver cancer" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,274, issued on Sept. 29, was assigned to Sun Yat-sen University (Guangzhou, China) and Sun Yat-sen University Cancer Center (Guangzhou, China).

"Use of BMP9 in combination with NK cell and PD-L1 antibody in preparing medicament for treating liver cancer" was invented by Tong Xiang (Guangzhou, China), Jianchuan Xia (Guangzhou, China), Yulong Han (Guangzhou, China) and Yao Zhu (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of using BMP9 in combination with an NK cell and a PD-L1 antibody in preparing a medicament for treating liver cancer is provided. Specifically, BMP9 is loaded on a drug carrier microbubble to give a BMP9...